Article Versions Notes

Mc Laughlin AM, Schmulenson E, Teplytska O, Zimmermann S, Opitz P, Groenland SL, Huitema ADR, Steeghs N, Müller L, Fuxius S, et al. Developing a Nationwide Infrastructure for Therapeutic Drug Monitoring of Targeted Oral Anticancer Drugs: The ON-TARGET Study Protocol. Cancers. 2021; 13(24):6281. https://doi.org/10.3390/cancers13246281

Mc Laughlin, Anna M., Eduard Schmulenson, Olga Teplytska, Sebastian Zimmermann, Patrick Opitz, Stefanie L. Groenland, Alwin D. R. Huitema, Neeltje Steeghs, Lothar Müller, Stefan Fuxius, and et al. 2021. "Developing a Nationwide Infrastructure for Therapeutic Drug Monitoring of Targeted Oral Anticancer Drugs: The ON-TARGET Study Protocol" Cancers 13, no. 24: 6281. https://doi.org/10.3390/cancers13246281

Mc Laughlin, A. M., Schmulenson, E., Teplytska, O., Zimmermann, S., Opitz, P., Groenland, S. L., Huitema, A. D. R., Steeghs, N., Müller, L., Fuxius, S., Illerhaus, G., Joerger, M., Mayer, F., Fuhr, U., Holdenrieder, S., Hempel, G., Scherf-Clavel, O., Jaehde, U., Kloft, C., & for the ON-TARGET Study Consortium. (2021). Developing a Nationwide Infrastructure for Therapeutic Drug Monitoring of Targeted Oral Anticancer Drugs: The ON-TARGET Study Protocol. Cancers, 13(24), 6281. https://doi.org/10.3390/cancers13246281